Markets
← Back to Stocks
IQV
IQVIA HOLDINGS INC
Health Care · Life Sciences Tools & Services
$166.37
-0.54%
Vol: 0.1M
Araverus Market Read
Thursday, March 19, 2026
IQVIA momentum builds from multiple analyst upgrades targeting $213
IQV fell 0.04% in pre-market to $178.43 on March 19, but benefited from March upgrades including TD Cowen to Buy with $213 target (+$39 raise) and Barclays to Overweight on March 6. Current stock at $174.49 with 21 analysts recommending buy versus none selling for overall Buy rating. Recent after-hours weakness of 0.81% reflects broader market dynamics despite positive fundamental shifts.
Price 50d 200d
Previous Market Reads
2 of 2 daysSector Peers
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| LLYELI | $916.83 | -0.13% | -11.4% | 21.8x | 0.43 | $821.2B |
| JNJJOHNSON | $237.56 | +0.16% | -1.8% | 18.9x | 0.33 | $572.6B |
| ABBVABBVIE | $206.31 | -0.97% | -11.4% | 12.8x | 0.33 | $364.6B |
| MRKMERCK | $114.17 | -0.29% | -5.4% | 11.7x | 0.26 | $282.3B |
| UNHUNITEDHEALTH | $280.37 | -1.29% | -2.2% | 14.1x | 0.38 | $254.5B |
| AMGNAMGEN | $349.90 | -0.42% | -6.3% | 15.0x | 0.42 | $188.6B |
| ABTABBOTT | $107.19 | -1.12% | -4.5% | 17.2x | 0.74 | $186.3B |
| GILDGILEAD | $141.06 | -0.17% | -8.6% | 14.7x | 0.37 | $175.2B |
| TMOTHERMO | $470.21 | +1.18% | -6.2% | 17.5x | 0.97 | $174.7B |
Fundamentals
Market Cap$28.2B
P/E (TTM)21.3
Forward P/E11.8
Beta1.41
Div Yield—
Prev Close$167.27
RSI (14-Day)
35Neutral
0305070100
52-Week Range
$134.65$166.37$247.05
From High-32.7%
From Low+23.6%
Moving Averages
50d SMA
$197.32-15.7%
200d SMA
$195.38-14.8%
Price below 200d MA — bearish structure.
Returns
1W
+2.1%
1M
-2.7%
3M
-24.9%
6M
-10.9%
1Y
-11.8%
YTD
-26.2%
Volume
Today90K
20d Avg2.1M
Ratio0.04x